Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5445 Journals

4171 Congresses

9600+ Unique Records

Tumour Virus Research

Title Abbreviation

Tumour Virus Res

Electronic ISSN

2666-6790

Therapeutic Area

Immunology, Internal Medicine, Molecular Medicine, Oncology, Public Health, Research, Vaccines, Virology

Readership

Cell Biologists, Clinicians, Epidemiologists, Immunologists, Molecular Biologists, Oncologists, Physicians - Medicine, Public Health Professionals, Researchers

Scope

Tumour Virus Research aims to publish primary research and review articles covering all aspects of virally driven neoplasia, ranging from basic molecular and cancer virology including virus-associated tumour models, diagnostics, vaccines, and therapies, through to clinical, epidemiological, and public awareness aspects. This open access journal is a forum for cross disciplinary work in tumour virus research and looks to build upon the expertise and unique insights that the study of different viruses can bring to the fields of cancer prevention and therapy." Tumour Virus Research aims to publish top quality articles, describing innovative research advances in the field of human tumour virology, including Epstein Barr virus (EBV), Human T cell leukemia virus (HTLV), Polyoma virus (PyV), Merkel Cell PolyomaVirus (MCPyV), Kaposi's Sarcoma Herpes Virus (KSHV) and Papillomaviruses (PV), as well as other related animal tumour virus models. The Editors particularly wish to encourage mechanistic studies, exploring fundamental cancer mechanisms that are relevant to how viruses drive malignant progression, but which are also able to inform cancer research in general. Papers describing the use of, for example, adenoviruses or other viruses as tools for investigating tumour biology, or as preventative or therapeutic agents are welcomed. This open access publication wishes to facilitate the publication of innovative articles of broad general appeal that bring together multifaceted contributions from virologists, immunologists, epidemiologists, clinicians and public health researchers. It seeks to promote dialogue and understanding of virus-induced cancers and to have a major impact on improvements to prevention, treatment and diagnosis in virus-associated tumours. Routine descriptive or repetitious studies are discouraged. The journal welcomes original research articles, reviews, short communications, and opinion articles. Our editorial board comprises expertise across the whole of tumour virology, ranging from basic virology (cellular and molecular biology), tumour immunology and disease epidemiology, to pre-clinical and clinical studies, diagnosis, prevention and therapy, as well as public health considerations.

Sponsoring Association(s)

No associations affiliated with this journal

Publisher Name

Elsevier B.V.

To see more details about Tumour Virus Research, Subscribe Now!

Submission to Acceptance Acceptance to Online Publication Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us